Inhibition of polo-like kinase 1 (PLK1) additively improves outcome of ionising irradiation (IR) in colorectal cancer (CRC)
Weng Ng(Sir Run Run Shaw Hospital), C.S. Lee(Liverpool Hospital), Jarrad Begg(Cancer Australia), B. Wang(UNSW Sydney), Tao Yang(Hospital of Hebei Province), Tara L. Roberts(Camden and Campbelltown Hospitals), Joo‐Shik Shin(Liverpool Hospital)
Cited by 1
Related Papers
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507
The mammalian PYHIN gene family: Phylogeny, evolution and expression
|BMC Evolutionary Biology|2012|202
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
|The Journal of Immunology|2003|174